Omega Healthcare Investors INC 8-K filings

NYSE
Omega Healthcare Investors announced first quarter 2024 results, exceeding expectations with increased net income and new investments.
NYSE
Omega Healthcare Investors has reached a proposed settlement in a shareholder derivative lawsuit, which includes corporate governance reforms and payment of attorney fees.
NYSE
Omega Healthcare Investors has filed a new automatic shelf registration statement, replacing a previous one, to continue its dividend reinvestment and at-the-market equity offering programs.
NYSE
Omega Healthcare Investors has reached a proposed settlement in shareholder derivative lawsuits, agreeing to implement significant corporate governance reforms.
NYSE
Omega Healthcare Investors announced its fourth quarter and full year 2023 results, including new investments and asset sales, while also providing adjusted FFO guidance for 2024.